Low Gradient Aortic Stenosis Won’t Improve with TAVR

Courtesy of Dr. Carlos Fava.

Low Gradient Aortic Stenosis Won’t Improve with TAVRIt is known that patients with low gradient aortic stenosis show poor evolution with medical treatment and, in addition, present high mortality rate with surgery. As regards TAVR, a far simpler procedure compared to surgery, there is contradicting evidence; while some studies claim it holds comparable risks, others have found benefits.

 

This study analyzed 8 studies including a total of 12,589 patients. Low gradient aortic stenosis was defined as aortic valve area (AVA) <1 cm2 with a mean gradient lower than 40 mmHg, except for Malkin, who defined it as AVA <1.

 

Primary end point was all cause mortality at 12 months, while the secondary was all cause mortality at 30 days.

 

All patients presented severe symptomatic aortic stenosis. 3,437 (27.3%) of them presented low gradient aortic stenosis.

 

Mean age was 81. Ejection fraction was lower in those presenting low gradient aortic stenosis (48% vs. 54%), higher presence of diabetes, coronary artery disease and EuroSCORE log.

 

Primary end point was higher in the low gradient AS group (OR; 1.48; 95% CI; 1.3-1.7; p<0.00001), as well as the secondary end point (OR, 1.35; 95% CI, 1.11-1.66; p=0.002). As regards age, ejection fraction, a history of heart disease and type of implanted valve, these factors did not impact mortality in the low gradient group.

 

Conclusion

In a population of patients undergoing TAVR, the presence of low gradient aortic stenosis seems to be associated to a dismal prognosis.

 

Comment

The presence of low flow and low gradient is a challenge in this disease, since it is associated with higher early mortality after surgery, and this analyzis shows the same.

We should learn to be wary not only of AS diagnosis (acknowledging symptoms, assessing ventricular function and ejection fraction), but also of systolic volume index, associated to early ventricular function deterioration.

 

Courtesy of Dr. Carlos Fava.

 

Original Title: Outcomes of Patients with Low-Pressure Aortic Gradient Undergoing Transcatheter Aortic Valve Implantation: a Meta-analysis.

Reference: Federico Carnotto, et al. Catheterization and Cardiovascular Intervention 2017;89:1100-1106.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....

TAVR in Pure Native Aortic Regurgitation: Are Dedicated Devices Truly Superior?

This systematic meta-analysis assessed the efficacy and safety of transcatheter aortic valve replacement (TAVR) in patients with pure native aortic regurgitation. The emergence of...

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....